Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands

Authors: Scott A McDonald, Alies van Lier, Dietrich Plass, Mirjam EE Kretzschmar

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

For accurate estimation of the future burden of communicable diseases, the dynamics of the population at risk – namely population growth and population ageing – need to be taken into account. Accurate burden estimates are necessary for informing policy-makers regarding the planning of vaccination and other control, intervention, and prevention measures. Our aim was to qualitatively explore the impact of population ageing on the estimated future burden of seasonal influenza and hepatitis B virus (HBV) infection in the Netherlands, in the period 2000–2030.

Methods

Population-level disease burden was quantified using the disability-adjusted life years (DALY) measure applied to all health outcomes following acute infection. We used national notification data, pre-defined disease progression models, and a simple model of demographic dynamics to investigate the impact of population ageing on the burden of seasonal influenza and HBV. Scenario analyses were conducted to explore the potential impact of intervention-associated changes in incidence rates.

Results

Including population dynamics resulted in increasing burden over the study period for influenza, whereas a relatively stable future burden was predicted for HBV. For influenza, the increase in DALYs was localised within YLL for the oldest age-groups (55 and older), and for HBV the effect of longer life expectancy in the future was offset by a reduction in incidence in the age-groups most at risk of infection. For both infections, the predicted disease burden was greater than if a static demography was assumed: 1.0 (in 2000) to 2.3-fold (in 2030) higher DALYs for influenza; 1.3 (in 2000) to 1.5-fold (in 2030) higher for HBV.

Conclusions

There are clear, but diverging effects of an ageing population on the estimated disease burden of influenza and HBV in the Netherlands. Replacing static assumptions with a dynamic demographic approach appears essential for deriving realistic burden estimates for informing health policy.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Liang SY, Mackowiak PA: Infections in the elderly. Clin Geriatr Med. 2007, 23 (2): 441-456. 10.1016/j.cger.2007.01.010. viii.CrossRefPubMed
4.
Fattovich G: Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003, 23 (1): 47-58. 10.1055/s-2003-37590.CrossRefPubMed
5.
6.
Simonsen L: The global impact of influenza on morbidity and mortality. Vaccine. 1999, 17 (Suppl 1): S3-S10.CrossRefPubMed
7.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003, 289 (2): 179-186. 10.1001/jama.289.2.179.CrossRefPubMed
8.
9.
Rothberg MB, Haessler SD, Brown RB: Complications of viral influenza. Am J Med. 2008, 121 (4): 258-264. 10.1016/j.amjmed.2007.10.040.CrossRefPubMed
10.
Kretzschmar ME, Mangen M-J, Pinheiro P, Jahn B, Fèvre EM, Longhi S, Lai T, Havelaar AH, Stein C, Cassini A, et al: New methodology for estimating the burden of communicable diseases in Europe. PLoS Med. 2012, 9 (4): e1001205-10.1371/journal.pmed.1001205.CrossRefPubMedPubMedCentral
11.
van Lier EA, Havelaar AH, Nanda A: The burden of infectious diseases in Europe: a pilot study. Euro Surveill. 2007, 12 (12): E3-E4.PubMed
12.
Murray CJL, Lopez AD: The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (Global burden of disease and injuries series I). 1996, Cambridge: Harvard School of Public Health on behalf of the World Health Organization and the World Bank
13.
McKay M, Beckman R, Conover WA: Comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics. 1979, 21 (2): 239-245.
14.
R Development Core Team: R: A Language and Environment for Statistical Computing. 2011, Vienna, Austria: R Foundation for Statistical Computing
15.
Statistics Netherlands (CBS): Immigration and emigration according to country of birth and age (31 December) and sex [Immi- en emigratie naar geboorteland, leeftijd (31 december) en geslacht]. 2011, Voorburg, NL: CBS, http://​statline.​cbs.​nl/​.
16.
Leslie PH: The use of matrices in certain population mathematics. Biometrika. 1945, 33 (3): 183-212. 10.1093/biomet/33.3.183.CrossRefPubMed
17.
Alter MJ, Mares A, Hadler SC, Maynard JE: The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol. 1987, 125 (1): 133-139.PubMed
18.
Ramsay ME, Balogun MA, Collins M, Balraj V: Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. Commun Dis Public Health. 1998, 1 (2): 89-94.PubMed
19.
World Health Organisation (WHO): Introduction of Hepatitis B vaccine into childhood immunization services. Management guidelines, including information for health workers and parents. 2001, Geneva: WHO
20.
Health Council of the Netherlands: General vaccination against hepatitis B revisited. 2009, The Hague: Health Council of the Netherlands
21.
Wielders CC, van Lier EA, van ’t Klooster TM, van Gageldonk-Lafeber AB, van den Wijngaard CC, Haagsma JA, Donker GA, Meijer A, van der Hoek W, Lugner AK, et al: The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health. 2012, 22 (1): 150-157. 10.1093/eurpub/ckq187.CrossRefPubMed
22.
Donker GA: Continuous Morbidity Registration Sentinel Stations the Netherlands 2010. 2011, Utrecht: Nivel
23.
Dijkstra F, van Gageldonk-Lafeber AB, van Brandsema PR, du Beest Holle M, Meijer A, van der Lubben IM, Wilbrink B, van der Sande MAB: Annual respiratory diseases report 2005/2006. [Jaarrapportage respiratoire infectieziekten 2005/2006]. 2006, Bilthoven: RIVM
24.
Elder AG, O’Donnell B, McCruden EA, Symington IS, Carman WF: Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993–4 epidemic: results of serum testing and questionnaire. BMJ. 1996, 313 (7067): 1241-1242. 10.1136/bmj.313.7067.1241.CrossRefPubMedPubMedCentral
25.
Lau LL, Cowling BJ, Fang VJ, Chan KH, Lau EH, Lipsitch M, Cheng CK, Houck PM, Uyeki TM, Peiris JS, et al: Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis. 2010, 201 (10): 1509-1516. 10.1086/652241.CrossRefPubMedPubMedCentral
26.
Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H: Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis. 2000, 19 (11): 834-842. 10.1007/s100960000376.CrossRefPubMed
27.
Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, Larrauri A, Meijer A, Puzelli S, Rizzo C, et al: Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr. 2010, 169 (8): 997-1008. 10.1007/s00431-010-1164-0.CrossRefPubMedPubMedCentral
28.
Dijkstra F, Donker GA, Wilbrink B, Van Gageldonk-Lafeber AB, Van Der Sande MA: Long time trends in influenza-like illness and associated determinants in The Netherlands. Epidemiol Infect. 2009, 137 (4): 473-479. 10.1017/S095026880800126X.CrossRefPubMed
29.
Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K: Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998, 178 (1): 53-60. 10.1086/515616.CrossRefPubMed
30.
van den Wijngaard CC, van Asten L, Koopmans MP, van Pelt W, Nagelkerke NJ, Wielders CC, van Lier A, van der Hoek W, Meijer A, Donker GA, et al: Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS One. 2012, 7 (2): e31197-10.1371/journal.pone.0031197.CrossRefPubMedCentral
31.
Jansen B, Tacken M, Mulder J, Visscher S, Tiersma W, Braspenning J: Monitoring vaccination rates: Dutch national influenza prevention programme 2010 [Monitoring vaccinatiegraad: Nationaal Programma Grieppreventie 2010]. 2011, Nijmegen: LINH
32.
Manfredi P, Williams JR: Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases. Measles in Italy as an example. Math Biosci. 2004, 192 (2): 153-175. 10.1016/j.mbs.2004.11.006.CrossRefPubMed
33.
Williams JR, Manfredi P: Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity. Int J Epidemiol. 2004, 33 (3): 566-572. 10.1093/ije/dyh098.CrossRefPubMed
34.
Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3 (11): e442-10.1371/journal.pmed.0030442.CrossRefPubMedPubMedCentral
35.
Bijkerk P, van Lier EA, van Vliet JA, Kretzschmar ME: Effecten van vergrijzing op infectieziekten. Ned Tijdschr Geneeskd. 2010, 154: A1613-PubMed
36.
Hahne SJ, de Melker HE, Kretzschmar M, Mollema L, van der Klis FR, van der Sande MA, Boot HJ: Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiol Infect. 2011, 140 (8): 1469-1480.CrossRefPubMed
37.
Veldhuijzen IK, Toy M, Hahne SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH: Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2010, 138 (2): 522-530. 10.1053/j.gastro.2009.10.039.CrossRefPubMed
Metadata
Title
The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands
Authors
Scott A McDonald
Alies van Lier
Dietrich Plass
Mirjam EE Kretzschmar
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-1046

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue

Research article

Health promotion services for patients having non-comminicable diseases: Feedback from patients and health care providers in Cape Town, South Africa

Research article

Insomnia and urban neighbourhood contexts – are associations modified by individual social characteristics and change of residence? Results from a population-based study using residential histories

Study protocol

Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial

Study protocol

Interventions to delay institutionalization of frail older persons: design of a longitudinal study in the home care setting

Study protocol

The Devon Active Villages Evaluation (DAVE) trial: Study protocol of a stepped wedge cluster randomised trial of a community-level physical activity intervention in rural southwest England

Research article

Masculinities and condom use patterns among young rural South Africa men: a cross-sectional baseline survey